This week, New Jersey became the 14 thstate to require mammography reports to include information for patients on breast density status and its implications on the risk of developing breast cancer.

Journals that have adopted the Standards for Reporting of Diagnostic Accuracy (STARD) feature CT coronary angiography studies that have been largely successful at complying with manuscript guidelines, according to a study published in the January issue of Radiology.

An ultrasound-CT protocol for appendicitis evaluation provides potentially larger savings over the standard CT-only protocol, according to a study published in the January 2014 issue of the American Journal of Roentgenology. 

Barco, a worldwide leader in enterprise visualization, has teamed up with Mammography Education Inc. to supply its latest mammography display systems and dedicated support for hands-on mammography CME courses designed to teach radiologists how to detect early-phase breast cancers.

Veterans Health Administration National Teleradiology Program (VA-NTP) is deploying its critical case management platform for all VA-NTP customers. Radiology staff serving Veterans in VA Medical Centers partnering with VA-NTP can get rapid turnaround for STAT Interpretations from NTP as well as continuous tracking of critical case data.

A decision aid may improve the decision making process of women 75 years and older regarding mammography screening, according to a study published on Dec. 20 in JAMA Internal Medicine.

The arterial phase of image acquisition has been shown to improve the detection of traumatic contained splenic vascular injuries, according to a study published in the January 2014 issue of Radiology. 

The United States Preventive Services Task Force (USPSTF) recommends that primary care providers screen asymptomatic women with a family history of breast, ovarian, tubal, or peritoneal cancers to determine if that family history is associated with an increased risk of potentially harmful mutations in breast cancer susceptibility genes BRCA1 or BRCA2, according to a recommendation statement published on Dec. 23 in the Annals of Internal Medicine.